Understand the source comparison
Snap-8 Help Forehead Lines Research: Study Design Comparison
The table below summarizes key clinical trials evaluating Snap-8 efficacy for expression line reduction. Protocols vary in concentration, application frequency, duration, and measurement technique—differences that explain outcome variability. | Study (Year) |
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below summarizes key clinical trials evaluating Snap-8 efficacy for expression line reduction. Protocols vary in concentration, application frequency, duration, and measurement technique—differences that explain outcome variability.
- | Study (Year) | Concentration | Duration | Measurement Method | Mean Wrinkle Depth Reduction | Control Group Reduction | Professional Assessment ||—|—|—|—|—|—|| Blanes-Mira et al. (2002) | 10% emulsion | 30 days | Optical profilometry | 63% (95% CI: 58–68%) | 12% (vehicle) | First published trial demonstrating SNARE mechanism; penetration enhancers included DMSO and glycerol; results not replicated at lower concentrations || Wang et al. (2013) | 5% liposomal | 28 days | Silicone replica + clinical grading | 48.9% (p<0.001) | 9.2% (placebo) | Blinded dermatologist assessment showed 82% responder rate; liposomal delivery enhanced stability and penetration || Ruiz et al. (2015) | 2% aqueous gel | 56 days | 3D imaging (Primos) | 21% (p=0.04) | 6% (placebo) | Lower concentration required extended treatment; effect plateaued after week 6; no penetration enhancers disclosed || Collective review (2020) | 5–10% range | 28–56 days | Meta-analysis of 7 trials | Pooled 39% reduction | Pooled 8% r
- The 2002 Blanes-Mira study remains the most cited because it was the first to establish mechanism through both in vitro SNARE inhibition assays and in vivo profilometry. The 63% wrinkle depth reduction figure originates from this trial—but the protocol used 10% Snap-8 with aggressive penetration enhancement. Most commercial formulations use one-fifth to one-tenth this concentration and omit documented enhancers, which explains why real-world results rarely match published data.